SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced preliminary revenue results for the second quarter ended December 31, 2024, and raised its fiscal 2025 revenue guidance. Preliminary Second Quarter Fiscal 2025 Highlights: Revenue of approximately $67.5 million, an increase of 31% from the prior year period, and up 43% sequentially f ...